Orrick advised Serve Robotics on the offering. Serve Robotics has entered into an equity distribution agreement that will enable it to raise up to $100 million...
You must be a Standard 1 Year member to access this content.
Orrick represented SupplyPike on the deal. SPS Commerce acquired SupplyPike for approximately $119 million in cash, net of cash acquired and $87 million in SPS Commerce...
You must be a Standard 1 Year member to access this content.
Orrick Herrington & Sutcliffe represented Serve Robotics in the offering, and Sichenzia Ross Ference Carmel reprensted the sole book-running managers. Serve Robotics Inc. (the “Company” or “Serve”),...
You must be a Standard 1 Year member to access this content.
Orrick represented TD Cowen and Stifel as joint book-running managers and representatives of several underwriters in the offering. Ichor Holdings, Ltd. executed a $125 million public offering....
You must be a Standard 1 Year member to access this content.
Orrick advised Squadra Ventures in the round. Tidal Cyber, the threat-informed defense company, announced that the company raised $5 million, led by Squadra Ventures with participation...
You must be a Standard 1 Year member to access this content.
Orrick Herrington & Sutcliffe LLP represented Kineta on the matter. Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology...
You must be a Standard 1 Year member to access this content.
Orrick Herrington & Sutcliffe LLP represented Fisker on the matter. Electric vehicle startup Fisker has announced plans to offer $170 million in unsecured convertible notes with...
You must be a Standard 1 Year member to access this content.
Orrick represented Fisker on the deal. Fisker has closed on $340 million in unsecured convertible notes with an original issue discount of 12 percent, resulting in...
You must be a Standard 1 Year member to access this content.
Orrick advised Catalyst Biosciences, Inc. on the deal. South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. announced its acquisition of the F351 program, a next-generation fibrosis drug,...
You must be a Standard 1 Year member to access this content.
Orrick advised CIIG Capital Partners II on the deal, while Latham & Watkins represented Zapp in the transaction. CIIG Capital Partners II, a U.S. publicly listed...
You must be a Standard 1 Year member to access this content.
Orrick advised Catalyst Biosciences, Inc. on the deal. South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. (NASDAQ: CBIO) announced the sale of its complement asset portfolio for...
You must be a Standard 1 Year member to access this content.
Orrick advised Fisker on the deal. Fisker (NYSE: FSR) announced the establishment of its at-the-market equity program with J.P. Morgan Securities and Cowen and Company as...
You must be a Standard 1 Year member to access this content.
